Stockscreener 앱 받기
12.30
0.24%
-0.03
Avid Bioservices Inc 주식(CDMO)의 최신 뉴스
Avid Bioservices Files Definitive Proxy Statement and Mails Letter to Stockholders - Marketscreener.com
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction - GlobeNewswire
Avid Bioservices Shareholders to Vote on $1.1B Buyout Deal at $12.50/Share Premium - StockTitan
Fmr LLC Increases Stake in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avid Bioservices, Inc. (CDMO) and Encourages Stockholders to Learn More About the Investigation - AccessWire
Lord Abbett & CO. LLC Takes $6.19 Million Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Avid Bioservices, Inc. (CDMO) Investors to Inquire about Securities Investigation - AccessWire
Avid Bioservices (CDMO) Can Exploit Potential U.S. BIOSECURE Act - MSN
Avid Bioservices' SWOT analysis: stock poised for private equity takeover By Investing.com - Investing.com Australia
GLAZER CAPITAL, LLC Acquires Significant Stake in Avid Bioservic - GuruFocus.com
Avid Bioservices' SWOT analysis: stock poised for private equity takeover - Investing.com India
Avid Bioservices: Fiscal Q2 Earnings Snapshot - CT Insider
Stephens keeps Avid Bioservices shares at Equal Weight on developments By Investing.com - Investing.com Canada
Avid Bioservices Reports Revenue Growth Amid Acquisition Plans - TipRanks
Vascular Disrupting Agents Market Top Companies StudyAGC - openPR
Avid Bioservices Reports Q2 Revenue of $33.5M, Misses Estimate; EPS at -$0.27, Wider Than Expected - GuruFocus.com
Avid Bioservices Inc. (CDMO) reports earnings - Quartz
Avid Bioservices, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 - Marketscreener.com
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024 - The Manila Times
Avid Bioservices earnings missed by $0.17, revenue fell short of estimates - Investing.com UK
Avid Bioservices Accepts $1.1B Buyout Offer as Q2 Revenue Surges 32% Despite Wider Losses - StockTitan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avid Bioservices, Inc. (CDMO) And Encourages Stockholders to Reach Out - AccessWire
(CDMO) On The My Stocks Page - Stock Traders Daily
Avid Bioservices (NASDAQ:CDMO) Stock Rating Lowered by Stephens - MarketBeat
Avid Bioservices gains as holder opposes $12.50 a share takeover - MSN
Point72 Asset Management L.P. Has $43.42 Million Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
CDMO (Avid Bioservices) EPS without NRI : $-2.27 (TTM As of Jul. 2024) - GuruFocus.com
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Avid Bioservices downgraded to Equal Weight from Overweight at Stephens - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, BRKH, CTV, EMKR on Behalf of Shareholders - GlobeNewswire Inc.
Parkman Healthcare Partners LLC Boosts Stock Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Cinctive Capital Management LP Raises Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Cannell Capital to vote against Avid Biosciences takeover - MSN
Cannell Capital to vote against Avid Biosciences takeover (NASDAQ:CDMO) - Seeking Alpha
CDMO Investors Have the Opportunity to Join Investigation of Avid Bioservices, Inc. with the Schall Law Firm - Business Wire
Avid Bioservices (STU:TEHN) Forward Dividend Yield % : 0.00% (As of Nov. 30, 2024) - GuruFocus.com
CDMO (Avid Bioservices) GF Value Rank : 8 (As of Nov. 30, 2024) - GuruFocus.com
CDMO (Avid Bioservices) Cash Flow for Lease Financing : $0.0 Mil (TTM As of Jul. 2024) - GuruFocus.com
CDMO (Avid Bioservices) Enterprise Value : $958.0 Mil (As of Dec. 01, 2024) - GuruFocus.com
CDMO (Avid Bioservices) Other Long-Term Liabilities : $0.4 Mil (As of Jul. 2024) - GuruFocus.com
CDMO (Avid Bioservices) GF Value Rank : 8 (As of Nov. 29, 2024) - GuruFocus.com
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Fisher Asset Management LLC - MarketBeat
Analysts Set Avid Bioservices, Inc. (NASDAQ:CDMO) Price Target at $13.63 - Defense World
Avid Bioservices, Inc. (NASDAQ:CDMO) Receives $13.63 Consensus Target Price from Analysts - MarketBeat
Avid Bioservices to be acquired for $1.1B in cash by GHO, Ampersand - MSN
Phocas Financial Corp. Purchases New Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Avid Bioservices' SWOT analysis: biomanufacturing stock faces acquisition, growth challenges - Investing.com Nigeria
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Royce & Associates LP - MarketBeat
Avid Bioservices, Inc. (CDMO): A Bull Case Theory - Insider Monkey
Janney Montgomery Scott LLC Buys 1,800 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
2.88%
2.65%
자본화:
|
볼륨(24시간):